Skip to content

Clinical trials

Purpura, Thrombocytopenic, Idiopathic trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Status: Unknown status Clear all

101 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20102
20112
20131
20144
20153
20167
20179
20185
20197
202012
202114
202218
202312
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status101

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University People's Hospital30
Shandong University17
Assiut University8
Sohag University5
Assistance Publique - Hôpitaux de Paris3
Gruppo Italiano Malattie EMatologiche dell'Adulto3
Institute of Hematology & Blood Diseases Hospital, China3
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology3
Jiangsu HengRui Medicine Co., Ltd.2
Seoul National University Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic101
Thrombocytopenia7
Lupus Erythematosus, Systemic5
Arthritis, Rheumatoid2
Connective Tissue Diseases2
Purpura2
Anemia, Aplastic1
Anemia, Hemolytic, Autoimmune1
Arthritis1
Arthritis, Juvenile1

Trials

Showing 76 to 100 of 101. Each trial links to its page on Pharma Observatory.

1 more trial matches. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.